Piscataway, NJ, October 18, 2023–Camber Pharmaceuticals is pleased to announce the addition of Darunavir Tablets to its current portfolio.
Darunavir Tablets are a human immunodeficiency virus (HIV-1) protease inhibitor indicated for the treatment of HIV-1 infection in adult and pediatric patients 3 years of age and older.
Darunavir 600 mg tablets are available in 60 count bottles.
To find out more about Darunavir Tablets please visit www.camberpharma.com
Camber Pharmaceuticals is a fully integrated pharmaceutical company. Its parent company, Hetero, of Hyderabad, India, is one of the world’s leading API and finished dose manufacturers. Camber is committed to bringing the highest quality generic pharmaceuticals to consumers and improving quality of life through cost-effective medications.
For more information, please contact your Sales Representative or Customer Service at [email protected] | 732.529.0430
